Heavy Cannabis Use Linked To Higher Head And Neck Cancer Risk, New Study Finds

Zinger Key Points
  • Daily cannabis use is linked to higher risks of developing head and neck cancers, especially in heavy users.
  • New study sparks crucial discussions on the impact of cannabis consumption methods and frequency on cancer development.
  • Experts highlight the complex relationship between cannabinoids and cancer, stressing the urgent need for more research.

A study published Thursday in JAMA Otolaryngology-Head & Neck Surgery suggests a link between daily, heavy cannabis use and an elevated risk of head and neck cancers. Led by Dr. Niels Kokot of Keck Medicine at the University of Southern California, the study analyzed data spanning two decades, involving over 4 million individuals across 64 U.S. health centers.

Cancer Risk And Cannabis Use Disorder

The research notes that individuals diagnosed with cannabis use disorder are between 3.5 and 5 times more likely to develop cancers of the mouth, throat and nasal cavity compared to non-users. These cancers are notably more prevalent in men and pose significant health risks, with survival rates drastically declining if the cancer metastasizes.

Experts believe the risks associated with cannabis might be due to the carcinogenic potential of cannabinoids and the smoke produced by combustion. “Cannabinoids themselves could be carcinogenic, and it could also be that the smoke itself has potential for carcinogenesis,” Kokot told NBC News. This distinction is crucial as cannabis continues to be primarily consumed through smoking.

Read Also: Marijuana Is Same As Heroin According To Nevada Supreme Court In Reversal Ruling That Cannabis Is A Schedule 1 Drug

Challenges Of Using Self-Reported Data

The study leveraged TriNetX’s extensive database to undertake the research. Despite inherent limitations of self-reported data like potential biases, the large sample size lends significant weight to the findings and suggests more research is needed to fully understand these associations.

Complex Role Of Cannabis In Cancer

The study’s findings also prompted discussions about the impact of frequency and method of ingestion on cancer risks. Dr. Joseph Califano, from UC San Diego's Gleiberman Head and Neck Cancer Center, underscored the study's importance due to the large sample size and detailed data. However, he clarified to CNN, “The occasional recreational use of marijuana does not show a significant association with head and neck cancer.”

This research adds a critical layer to the ongoing debate about the safety of cannabis, particularly as legalization spreads and usage rates climb. With head and neck cancers contributing to 4% of all cancers in the U.S., understanding these risks is more relevant than ever.

Cannabis’s role in cancer is complex, as highlighted by Califano in an editorial accompanying the study, “Some of them may be associated with cancer development, some may actually inhibit cancer development.” 

Further Research Needed On Cannabis Risks

Such duality underscores the need for further research to better understand cannabis’s health implications, balancing its therapeutic potential against its risks. "This underscores the importance to inform people about the potential risks and conduct further research to understand the long-term impacts of cannabis use on cancer development," said Kokot.

Read Next:

Photo: Elsa Olofsson On Unsplash.

CCC banner https://www.benzinga.com/events/cannabis-conference/
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsHealth Carecannabis and cancerJoseph CalifanoNiels Kokot
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.